Long-term results of the UCSF-LBNL randomized trial: Charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanoma

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 2, 2015, Pages 376-383

  Mishra, Kavita K ^a   Quivey, Jeanne M ^a,b   Daftari, Inder K ^a,b   Weinberg, Vivian ^a   Cole, Tia B ^c   Patel, Kishan ^a   Castro, Joseph R ^a,b   Phillips, Theodore L ^a,b   Char, Devron H ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c Tumori Foundation   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHARGED PARTICLES; DERMATOLOGY; DISEASE CONTROL; HELIUM; IODINE; ONCOLOGY; REGRESSION ANALYSIS; TUMORS;

DISEASE FREE SURVIVAL; ELIGIBILITY CRITERION; LIKELIHOOD RATIO TESTS; LOCAL TUMOR CONTROL; LONG-TERM OUTCOME; LONG-TERM RESULTS; METHODS AND MATERIALS; PARTICLE RADIATION THERAPIES;

PATIENT TREATMENT;

IODINE 125; HELIUM; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOROID MELANOMA; CILIARY BODY MELANOMA; CILIARY BODY TUMOR; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENUCLEATION; FEMALE; FOLLOW UP; HELIUM ION RADIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEOVASCULAR GLAUCOMA; OPTIC DISK; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FOVEA; THICKNESS; TREATMENT DURATION; VISUAL ACUITY; BRACHYTHERAPY; CHOROID NEOPLASMS; CILIARY BODY; CONSERVATIVE TREATMENT; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; RADIATION DOSE; STATISTICS AND NUMERICAL DATA; TIME; UVEAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHOROID NEOPLASMS; CILIARY BODY; DISEASE-FREE SURVIVAL; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HELIUM; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; ORGAN SPARING TREATMENTS; RADIOTHERAPY DOSAGE; TIME FACTORS; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84928938502     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.01.029     Document Type: Article

References (36)

1. D.H. Char, T. Phillips, and I. Daftari Proton teletherapy of uveal melanoma Int Ophthalmol Clin 46 2006 41 49
2. J.R. Castro, D.H. Char, and P.L. Petti 15 years experience with helium ion radiotherapy for uveal melanoma Int J Radiat Oncol Biol Phys 39 1997 989 996
3. S. Toyama, H. Tsuji, and N. Mizoguchi Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: Usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of NVG Int J Radiat Oncol Biol Phys 86 2013 270 276
4. B. Damato, A. Kacperek, and M. Chopra Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience Int J Radiat Oncol Biol Phys 62 2005 1405 1411
5. A. Courdi, J.P. Caujolle, and J.D. Grange Results of proton therapy of uveal melanomas treated in Nice Int J Radiat Oncol Biol Phys 45 1999 5 11
6. E.S. Gragoudas Proton beam irradiation of uveal melanomas: The first 30 years - The Weisenfeld Lecture Invest Ophthalmol Vis Sci 47 2006 4666 4673
7. R. Dendale, L. Lumbroso-Le Rouic, and G. Noel Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay proton therapy center Int J Radiat Oncol Biol Phys 65 2006 780 787
8. C. Mosci, S. Mosci, and A. Barla Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France Eur J Ophthalmol 19 2009 654 660
9. M.W. Wilson, and J.L. Hungerford Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma Ophthalmology 106 1999 1579 1587
10. M. Fuss, L.N. Loredo, and P.A. Blacharski Proton radiation therapy for medium and large choroidal melanoma: Preservation of the eye and its functionality Int J Radiat Oncol Biol Phys 49 2001 1053 1059
11. E. Egger, A. Schalenbourg, and A. Zografos Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma Int J Radiat Oncol Biol Phys 51 2001 138 147
12. M.Y. Chang, and T.A. McCannel Local treatment failure after globe-conserving therapy for choroidal melanoma Br J Ophthalmol 97 2013 804 811
13. Z. Wang, M. Nabhan, and S.E. Schild Charged particle radiation therapy for uveal melanoma: A systematic review and meta-analysis Int J Radiat Oncol Biol Phys 86 2012 18 26
14. A.M. Allen, T. Pawlicki, and L. Dong An evidence based review of proton beam therapy: The report of ASTRO's emerging technology committee Radiother Oncol 103 2012 8 11
15. National Institutes of Health and National Cancer Institute. Planning for a national center for particle beam radiation therapy research (P20), P20 exploratory grant call, posted Oct 17, 2013. Available at: http://grants.nih.gov/grants/guide/pa-files/PAR-13-371.html. Accessed July 20, 2014.
16. D.H. Char, J.M. Quivey, and J.R. Castro Helium-ions versus iodine 125 brachytherapy in the management of uveal melanoma - A prospective, randomized, dynamically balanced trial Ophthalmology 100 1993 1547 1554
17. M. Goitein, and T. Miller Planning proton therapy of the eye Med Phys 10 1983 275 283
18. C.C. Ling, G.T.Y. Chen, and J.W. Boothby Computer assisted treatment planning for I-125 ophthalmic plaque radiotherapy Int J Radiat Oncol Biol Phys 17 1989 405 410
19. S. Nag, J.M. Quivey, and J.D. Earle The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas Int J Radiat Oncol Biol Phys 56 2003 544 555
20. L.M. Jampol, C.S. Moy, and T.G. Murray The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19 Ophthalmol 109 2002 2197 2206
21. S.N. Badiyan, R.C. Rao, and A.J. Apicelli Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy Int J Radiat Oncol Biol Phys 88 2014 801 805
22. J.R. Castro, W.M. Saunders, and C.A. Tobias Treatment of cancer with heavy charged particles Int J Radiat Oncol Biol Phys 8 1982 2191 2198
23. D.E. Charlton The range of high LET effects from I125 decays Radiat Res 107 1986 163 171
24. J.M. Quivey, J. Augsburger, and L. Snelling I-125 plaque therapy for uveal melanoma: Analysis of the impact of time and dose factors on local control Cancer 77 1996 2356 2362
25. E. Hall, and D. Brenner The dose-rate effect revisited: Radiobiological considerations of importance in radiotherapy Int J Radiat Oncol Biol Phys 21 1991 1403 1414
26. R. Amdur, and J. Bedford Dose-rate effects between 0.3 and 30 Gy/h in a normal and a malignant human cell line Int J Radiat Oncol Biol Phys 30 1994 83 90
27. C. Yang, K. Olsen, and J. Schwade Dose rate effect of 125I irradiation on normal rabbit eyes and experimental choroidal melanoma Exp Eye Res 1993 577 585
28. B.A. Perez, P. Mettu, and L. Vajzovic Uveal melanoma treated with iodine-125 episcleral plaque: An analysis of dose on disease control and visual outcomes Int J Radiat Oncol Biol Phys 89 2014 127 136
29. K.K. Mishra, I.K. Daftari, and V. Weinberg Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: A detailed analysis of tumor and dose-volume parameters Int J Radiat Oncol Biol Phys 87 2013 330 336
30. W.J. Meecham, S.M. Kroll, and D.H. Char Helium ion radiation-dosimetry and anterior segment complications Invest Ophthalmol Vis Sci 33 1992 1253
31. M.K. Kim, D.H. Char, and J.L. Castro NVG after helium ion irradiation for uveal melanoma Ophthalmology 93 1986 189 193
32. I.K. Daftari, D.H. Char, and L.J. Verhey Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma Int J Radiat Oncol Biol Phys 39 1997 997 1010
33. I.K. Daftari, T.R. Renner, and L.J. Verhey New UCSF proton ocular beam facility at the Crocker nuclear laboratory cyclotron (UC Davis) Nucl Instrum Methods A 380 1996 597 612
34. J.A. Sivak-Callcott, D.M. O'Day, and J.D. Gass Evidence-based recommendations for the diagnosis and treatment of NVG Ophthalmology 108 2001 1767 1776
35. C. Costagliola, U. Cipollone, and M. Rinaldi Intravitreal bevacizumab (Avastin (R)) injection for NVG: A survey on 23 cases throughout 12-month follow-up Brit J Clin Pharmacol 66 2008 667 673
36. Collaborative Ocular Melanoma Study Group The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28 Arch Ophthalmol 124 2006 1684 1693